zacks novo nordisk - Search News

News

Novo Nordisk, Value Investors Buy

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

Novo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Yahoo Finance · 19h

Here's Why Novo Nordisk (NVO) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Seeking Alpha · 1d

Novo Nordisk: Watching Value Investors Buy The Dip Hurts My Eyes

Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I rate NVO stock a Hold.

19h

The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly

Pfizer beats Q2 estimates with rising oncology sales, new drug launches, and strong Seagen-driven portfolio growth.

Why I Tripled My Novo Nordisk Position

Novo Nordisk's steep stock decline has pushed it into deep undervaluation, now trading at attractive multiples below ...

13d

Novo Nordisk Stock Hits New 52-Week Low Amid Profit Warning: What Investors Need To Know

Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session ...

Novo Nordisk: Q2 Earnings Snapshot

BAGSVAERD, Denmark (AP) — BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported second-quarter profit of $4.03 billion. On a per-share basis, the Bagsvaerd, Denmark-based company said ...

CBS News14d

Novo Nordisk shares fall 20% after company names new CEO and lowers its ...

Novo Nordisk shares plunged over 20% on Tuesday after the company named a new CEO and lowered its profit expectations, citing weaker sales of its popular weight-loss drug Wegovy due to competition ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results